UPDATE: Jefferies Starts Nektar Therapeutics (NKTR) at Buy
Tweet
Share
E-mailGet Alerts NKTR Hot Sheet
Price: $74.53 --0%
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Rating Summary:
20 Buy, 8 Hold, 4 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 7 | Down: 5 | New: 25
Join SI Premium – FREE
Jefferies initiates coverage on Nektar Therapeutics (Nasdaq: NKTR) with a Buy rating and $9.50 price target.
The firm comments, "Nektar has built a pegylation delivery platform that is the engine of its drug development efforts. With the company’s six clinical stage assets, of which half are unpartnered, we expect data flow across these multiple programs will drive shares higher over the next 12-18 months. The most important catalyst, near-term, is Ph III naloxegol data in opioid-induced constipation (OIC) which should be available in the next 6-9 months."
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $6.61 yesterday.
The firm comments, "Nektar has built a pegylation delivery platform that is the engine of its drug development efforts. With the company’s six clinical stage assets, of which half are unpartnered, we expect data flow across these multiple programs will drive shares higher over the next 12-18 months. The most important catalyst, near-term, is Ph III naloxegol data in opioid-induced constipation (OIC) which should be available in the next 6-9 months."
For an analyst ratings summary and ratings history on Nektar Therapeutics click here. For more ratings news on Nektar Therapeutics click here.
Shares of Nektar Therapeutics closed at $6.61 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JPMorgan Reinstates Nektar Therapeutics (NKTR) at Neutral
- Keefe, Bruyette & Woods Resumes Toronto-Dominion Bank (TD:CN) (TD) at Market Perform
- Baird Starts Eaton Corporation (ETN) at Outperform
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
Jefferies & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
